Mumps News and Research

RSS

Mumps is a viral disease characterized by fever, headache, muscle weakness, stiff neck, loss of appetite, swelling and tenderness of one or more of the salivary glands situated along the angle of the jaw and inside the mouth, including the parotid gland located within the cheeks just below the front of the ear.

Measles exposure in Philadelphia and Lancaster counties

The Pennsylvania Department of Health and the Philadelphia Department of Public Health are advising the public of exposure to a case of measles in Lancaster and Philadelphia counties.

24 Aug 2011

Sinovac second quarter sales increase 52.5% to $15.7 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2011.

12 Aug 2011

Chicken pox vaccine reduced related deaths by 88%

The team of researchers found that although in 2006 a second dose was added to the vaccination roster, the decrease in deaths occurred largely during the time when just one shot was recommended. While chickenpox-related deaths are now relatively rare, the new two-dose regimen may eliminate them altogether, they said. The double dose will further reduce sick days and medical care associated with chickenpox and its complications, the study authors said.

25 Jul 2011

Berks County's Department of Health advises public about possible measles exposure

The state Department of Health is advising the public of a possible case of measles exposure in Morgantown, Berks County.

15 Jul 2011

Most cases of facial nerve paralysis in children can be treated successfully

A half-paralyzed face with a motionless, drooping side can be alarming at any age, but when it occurs in a child it can be especially devastating.

30 Jun 2011

Novartis Bexsero pivotal study data on meningococcal serogroup B presented at ESPID

New data from a pivotal study in more than 1,800 infants show that Novartis candidate vaccine Bexsero induces a robust immune response to meningococcal serogroup B when given alone or when co-administered with other routine vaccines.

15 Jun 2011

Largest number of measles cases in the US since 1996: Report

According to the latest report from the Centers for Disease Control and Prevention (CDC), the United States has had 118 measles cases so far this year, the most for this date since 1996, and close to 90% of them are linked to cases in other countries.

24 May 2011

Sinovac first quarter sales increase 5.3% to $4.7 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period ended March 31, 2011.

13 May 2011

Ahead of Immunization Week, WHO calls for countries to come together to control measles outbreak in Europe

WHO is urging countries in Europe to join together to help control the measles outbreak that has grown to more than 6,500 cases in 33 countries and the potential for worsening outbreaks "in the days ahead as people travel during the Easter holidays," U.N. News Centre reports.

25 Apr 2011

FDA approves Sanofi Pasteur's meningococcal vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra, to include a two-dose schedule for infants and children 9 months through 23 months of age.

25 Apr 2011

Also in global health news: Nuclear accidents; measles outbreak in Europe; funding shortfall in Zimbabwe; drinking water in Pakistan; agricultural development in S. Asia

The world must prepare for more major nuclear accidents, U.N. Secretary-General Ban Ki-moon said on Wednesday at a Kiev conference marking the explosion of a reactor at Ukraine's Chernobyl nuclear reactor 25 years ago, the Associated Press reports.

22 Apr 2011

Cervical cancer vaccine target falls short: Report

Data from the Australian federal government shows that the target to immunize 80 per cent of 12-year-old girls against cervical cancer is not being met because many of them are failing to have all three doses of the vaccine. This potentially undermines the effectiveness of the $436 million program started in 2007.

19 Apr 2011

Sinovac reports fourth quarter net sales of $9.1 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its fourth quarter and full year financial results periods ended December 31, 2010.

31 Mar 2011

U-M professors recommend certain steps to reach research equipoise

In 1998, a study linking the measles, mumps and rubella vaccine to autism in children appeared in a respected medical journal. For a decade, the study grabbed headlines worldwide.

23 Mar 2011

Positive preliminary results from Sinovac EV71 vaccine phase I trial in adults

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today the unblinding of the Phase I clinical trial results for the adult population for its proprietary inactivated vaccine against human enterovirus 71, which causes hand, foot, and mouth disease.

10 Mar 2011

Study: Vaccinated children and adolescents are less prone to infectious diseases

May vaccinations put too much strain on or weaken children's immune systems and are therefore harmful? Roma Schmitz and her colleagues from the Robert Koch Institute investigate exactly this research question in the current issue of Deutsches Ärzteblatt International.

4 Mar 2011

Sinovac submits clinical trial application for 13-valent pneumococcal conjugate vaccine to China SFDA

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its 13-valent pneumococcal conjugate vaccine (PCV) to China's State Food and Drug Administration (SFDA) on March 3, 2011.

3 Mar 2011

Merck reports GAAP net income of $861 million for 2010

Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the fourth quarter of $0.88, which excludes purchase accounting adjustments, restructuring costs and merger-related expenses.

4 Feb 2011

Measles warnings for Australia and New Zealand

In a flight from Brisbane that arrived in Auckland two weeks ago, a child was confirmed to have measles and has been taken to hospital. Five other cases of the virus have been confirmed. At present a further 100 cases are being investigated by the Auckland Regional Public Health Service.

26 Jan 2011

Viewpoints: Health law repeal; Individual mandate; Essential benefits package; Arizona transplant program

If the government fails, then costs will rise inexorably. Nothing in the law guarantees success: The law embodies almost every idea anyone has offered and hopes a couple of them will work.

14 Jan 2011